re001 t cell
Cell therapyexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2024 (NCT06546150)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- GTPase KRasImmunity, active
KRAS immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06545201 | Phase 1 | Aug 1, 2024 | Henan Medical University |
| NCT06546150 | Phase 1 | Aug 1, 2024 | Henan Medical University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Henan Medical University | Academic/Hospital | 2 | 2 | 1 | 2024 |
1 organizations
Page 1 / 1